Jack Sidorov Senior Counsel

Washington, DC
T 202.753.3799 | F 202.753.3838



Jack brings 36 years of experience at the U.S. Department of Justice (DOJ) Antitrust Division to his practice, which focuses on advising on antitrust issues and premerger notification requirements. He is a noted authority on premerger notification law, and his 2014 addition to the firm “bolster[ed] Lowenstein’s ability to provide M&A counsel to private equity, hedge fund, and venture capital clients” (Law 360).

Prior to joining the Washington, D.C. office of the firm, Jack served as the DOJ’s primary expert on premerger notification law, procedures, and policies under the Hart-Scott-Rodino (HSR) Act, providing HSR-related advice to the Assistant Attorney General for Antitrust and throughout the Antitrust Division. He worked closely with the Federal Trade Commission’s (FTC’s) Premerger Notification Office on numerous HSR rulemakings, including rules promulgating HSR exemptions (1996), implementing legislative changes to the HSR Act (2002), revising the HSR treatment of partnerships and limited liability companies (2005), and making substantial changes to the HSR Form designed to improve the utility of the form to the FTC and DOJ while reducing burden on filing parties (2011).

Jack played a leading role in roughly 50 civil penalty compliance cases brought under the HSR Act, working to develop and articulate the legal theories underlying these cases, up to and including the DOJ’s November 2014 case alleging and settling gun-jumping claims against Flakeboard and SierraPine. The settlement required the companies to pay a combined $3.8 million in civil penalties for violating the HSR Act, and further required Flakeboard to disgorge an additional $1.15 million in illegally obtained profits for violating Section 1 of the Sherman Antitrust Act.

Working with the Antitrust Division’s Foreign Commerce Section, Jack regularly counseled other countries on premerger notification law and best practices through various international antitrust bodies, including the International Competition Network–which he continues to participate in–and the OECD Competition Committee.

While at the DOJ, Jack also advised on a range of non-HSR issues, from monopolization law relating to loyalty discounts and other unilateral conduct to antitrust issues arising in the context of college and professional sports. Early in his career, Jack was part of the DOJ’s AT&T Relief Task Force, developing plans for the relief ultimately obtained in the monopolization case against AT&T and preparing the relief case for trial.

Before embarking on his legal career, Jack founded and served as Commissioner of the World Stickball Association, which played its games on the campus of Harvard Law School. His walk-off home run, which propelled the Long Island Sound to victory over the Prague Noses in Stickbowl III, was featured on NBC.

Publications

2017 HSR Thresholds Announced by Federal Trade Commission
Antitrust & Trade Regulation Client Alert, January 26, 2017
Jack Sidorov, Jeffrey Blumenfeld, Jeffrey Shapiro
The Outlook For Hart-Scott-Rodino Under President Trump
Law360, January 13, 2017
Jack Sidorov
BNA Insights: DOJ’s ValueAct HSR Compliance Case Raises Four Questions That Are Hard to Pass Over
Bloomberg BNA, June 27, 2016
Jack Sidorov
View More...

Press Mentions

In The Capitol ForumJack Sidorov discusses HSR Act compliance issues raised by stock acquisitions made in the context of a hostile takeover battle. , The Capitol Forum , June 25, 2015
Lowenstein Sandler represented Indorama Ventures Public Company Limited (IVL), a world-leading producer of intermediate petrochemicals, in connection with its acquisition of the PTA business of CEPSA Chimie Montréal s.e.c in Montreal, Canada from Cepsa Química SA, wholly-owned affiliate of Cepsa, and IQ CHIMIE INC., a subsidiary of Investissement Québec. The 600,000 tonne PTA plant will provide Indorama Ventures with feedstock security to better serve its customers and will enhance Indorama Ventures’ position in North America. The transaction was completed on June 1, 2015. The Lowenstein deal team was led by Nicholas San Filippo IV and Ethan A. Skerry and also included Sam E. Khan, Casey O’Connor, Eugene Cheval, Robert Bee, Jr., Jeffrey M. Shapiro and Jack D. Sidorov. , June 1, 2015
Lowenstein Sandler represented Pernix Therapeutics Holdings Inc. in its acquisition of the Zohydro® ER Franchise from Zogenix Inc. Under terms of the agreement, Pernix, through its wholly-owned subsidiary, Ferrimill Limited, paid Zogenix $70 million in cash, issued to Zogenix 1,682,086 shares of Pernix common stock and deposited an additional $10 million in cash in escrow to fund potential indemnification claims for a period of 12 months following the closing. Pernix also purchased certain Zohydro ER inventory. The Lowenstein deal team is led by Michael Lerner, Herschel Weinstein, and Park Bramhall, and also included Lowell A. Citron, Marc Kurzweil, Brian A. Silikovitz, Christina Iafe, Jack D. Sidorov, Jeffrey M. Shapiro, Hilla Shimshoni, Tara P. D'Orsi, Michael Amalfe, Sarah Saladini and Eugene Cheval. , April 24, 2015
View More...

Related Areas

Antitrust & Trade Regulation
Litigation
White Collar Criminal Defense

Education


Harvard Law School ( J.D. , 1976 ) , magna cum laude
Johns Hopkins University ( B.A. , 1973 ) , Quantitative Studies with concentration in Economics, General Honors, Phi Beta Kappa

Bar Admissions


District of Columbia